Contact Information: INVESTOR CONTACT: Debbie Bailey 631-444-8090 fax: 631-444-8848 MEDIA CONTACT: Janice Meraglia 631-444-6293 fax 631 444-8848 FCMN Contact: Web site: http://www.adnas.com
Applied DNA Sciences Succeeds in Trial UK Textile Contract
SigNature DNA Protects the "Made in Yorkshire, England" Label for Wool
| Source: Applied DNA Sciences
STONY BROOK, NY--(Marketwire - February 24, 2009) - Applied DNA Sciences, Inc. (OTCBB : APDN ), a
provider of DNA-based security solutions completed the successful
application of SigNature® DNA at every stage of the woolen textile
manufacturing process in Yorkshire, UK. This first phase of the "DNA in
Textiles" project was fully funded by Yorkshire Forward in collaboration
with the Textile Centre of Excellence, and its consortium of companies.
Applied DNA is embarking on the next phase of our wool protection program,
a multimillion dollar commercialization program, which will likely include
second-phase funding from Yorkshire Forward.
"We see the importance and relevance of using DNA to safeguard our brands
and our industry here in Yorkshire," commented Bill Macbeth, Managing
Director, Textile Centre of Excellence. "We need to protect the quality and
reputation of the textiles and apparel we make. It's simple really, we
manufacture the best woolen cloth in the world and DNA can be effective in
helping us to combat the rising tide of counterfeit goods."
All the work was done in close collaboration with local Yorkshire
manufacturers, weavers, finishers and tailors. Applied DNA demonstrated
the ease of application of SigNature DNA to wool at each stage. Most
importantly, the company proved the ability of SigNature DNA to withstand
different textile manufacturing processes, including dyeing, scouring,
washing and dry cleaning. SigNature DNA was authenticated unequivocally at
every stage of manufacture.
Paul Johnson, Managing Director of collaborating company, WT Johnson &
Sons, commented: "DNA is real and it's practical. Our clients demand the
highest quality and best-performing fabrics in the world. APDN adds value
to our products and our business by ensuring that our customers are getting
exactly what they paid for. We look forward to making this available to the
rest of the world."
Wool is a freely traded international commodity often crossing multiple
borders during the manufacturing process. Prior to SigNature DNA, there
was no reliable way to track wool during this process. Global production of
wool is now more than 3.1 billion pounds annually (Purdue University). The
total yearly retail sales value of wool products is around $80 billion
(Woolmark).
Mr. Jim Farmery, Assistant Director for Business, Yorkshire Forward,
commented: "The cutting edge technology utilized by APDN in collaboration
with the Yorkshire companies has led to the development of products and
processes fit for the 21st century. We are delighted to support this work,
and look forward to extending the range and coverage of this important
anti-counterfeiting activity to protect Yorkshire brands and products."
About Applied DNA Sciences, Inc.
Applied DNA Sciences markets and sells DNA security solutions to protect
products, brands, and intellectual property from counterfeiting and
diversion. Its patented technologies sold under SigNature DNA use DNA from
plants to mark and authenticate products in a unique manner that
essentially cannot be copied. Applied DNA also provides BioMaterial
GenoTyping™ services by using genomic DNA present in natural materials
to identify the original source of DNA present in finished products. Both
platform technologies protect brands and products in a wide range of
industries and provide a forensic chain of evidence to enable enforcement
agencies to prosecute perpetrators. To learn more, go to www.adnas.com.
APDN's common stock is listed on the Over-The-Counter Bulletin Board under
the symbol "APDN."
The statements made by APDN may be forward-looking in nature and are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements describe APDN's future
plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of which
are beyond the control of APDN. Actual results could differ materially from
those projected due to our short operating history, limited financial
resources, limited market acceptance, market competition and various other
factors detailed from time to time in APDN's SEC reports and filings,
including our Annual Report on Form 10-K, filed on December 16, 2008 and
our subsequent quarterly reports on Form 10-Q. APDN undertakes no
obligation to update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to reflect the
occurrence of unanticipated events.